跳至主要内容
临床试验/CTRI/2020/10/028436
CTRI/2020/10/028436招募中不适用

Role of Biomarkers and it’s trend to predict the outcome of COVID patients, retrospective review

Dr Amarja Havaldar1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2020年10月25日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
130
试验地点
1
主要终点
To study the trend of biomarkers and it’s effect on outcome (ICU mortality)in patients admitted with the diagnosis of COVID pneumonia.

研究概览

简要总结

Use ofvarious biomarkers is being investigated and proposed biomarkers are C reactiveprotein CRP, LDH, D Dimer, Ferritin, Troponin I , Procalcitonin and IL 6. Useof these various biomarkers has been studied widely and can be suggested to beused for prognostication. The simple biomarker such as Neutrophil/ Lymphocyteratio also can help in predicting outcome.

The aim of our study is to evaluatethe trend of various biomarkers done for these patients and can it be used topredict the outcome of COVID 19 patients.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Patients with COVID 19 pneumonia admitted in ICU.

排除标准

  • 未提供

结局指标

主要结局

To study the trend of biomarkers and it’s effect on outcome (ICU mortality)in patients admitted with the diagnosis of COVID pneumonia.

时间窗: ICU mortality or at the end of 4 weeks | Hospital mortality or at the end of 90 days

次要结局

  • 1.To study the number of ventilator free days(2. To study the difference in ICU length of stay)

研究者

发起方
Dr Amarja Havaldar
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验